Safety & Side Effects of GLP-1 Microdosing GLP-1 microdosing is designed to be gentler than full-dose therapy, but its still a prescription medication and should be used under medical supervision
Karen Basbaum, Chief Business Officer Number Of Employees: ~63 Stage: Publicly traded Financial Snapshot: The market cap for July 2026 is $2.81 billion
From managing blood sugar levels to supporting significant weight loss, these treatments offer a new frontier for patients struggling with complex digestive and endocrine concerns
Managing drug spend without compromising care As the leading pharmacy benefit manager (PBM), we help clients deliver clinically sound, cost-effective medication coverage that supports their goals and their members health
Effects of glucagon-like peptide-1 receptor agonists on incidence of hepatocellular carcinoma and liver decompensation in patients with diabetes: a systematic review and meta-analysis
There is no known pharmacokinetic interaction that necessitates separation of probiotic intake from the weekly Ozempic injection